Virtual screening of marine coumarins and xanthenes identifies novel acid-suppressive leads targeting histamine H₂ receptor and gastric proton pump
Biomolecules and Biomedicine · 2026
DOI: 10.17305/bb.2026.13660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2026. Verfasst von Amar Osmanović und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Coumarins, Xanthenes, Receptors, Histamine H2, H(+)-K(+)-Exchanging ATPase. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Marine natural products represent a diverse collection of structurally distinct metabolites, many of which have untapped therapeutic potential. This study screened 161 marine-derived coumarin and xanthene compounds for their binding affinity to the histamine H₂ receptor and the gastric H⁺/K⁺-ATPase, the primary regulators of gastric acid secretion. Docking simulations were performed using curated structures of both targets, followed by an evaluation of the compounds for drug-likeness and predicted absorption, distribution, metabolism, and excretion (ADME) properties. Thirty-four compounds demonstrated a stronger predicted affinity for the H₂ receptor than famotidine; however, only three compounds (1, 5, and 150) met all drug-likeness criteria, achieving quantitative estimates of drug-likeness (QED) values exceeding 0.67. Screening against the proton pump yielded 98 hits with higher affinity than soraprazan, with compound 150 being the only candidate to fulfill all medicinal chemistry filters. Interaction analysis indicated that compound 150 binds to the proton pump in a manner that largely overlaps with soraprazan. Density functional theory (DFT) calculations were utilized to characterize the electronic properties of the most promising compounds. ADME predictions suggested favorable permeability and a low risk for human ether-à-go-go-related gene (hERG) inhibition, although high plasma protein binding and the potential for cytochrome P450 (CYP) inhibition may require further optimization. These findings underscore the potential of pyranocoumarin compound 150, along with xanthene derivatives 1 and 5, as promising candidates for the development of new acid-suppressive agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina.
- Gastroenterohepatology Clinic, Clinical Center of University of Sarajevo, Sarajevo, Bosnia and Herzegovina; University of Sarajevo, Faculty of Health Studies, Sarajevo, Bosnia and Herzegovina.
- Department of Pharmacy, "G.d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Zitieren
APA
Osmanović, A., Salihović, M., Mehmedović, A., Turalić, A., Veljović, E., Pazalja, M., Carradori, S., & Špirtović-Halilović, S. (2026). Virtual screening of marine coumarins and xanthenes identifies novel acid-suppressive leads targeting histamine H₂ receptor and gastric proton pump. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.13660
Vancouver
Osmanović A, Salihović M, Mehmedović A, Turalić A, Veljović E, Pazalja M, et al. Virtual screening of marine coumarins and xanthenes identifies novel acid-suppressive leads targeting histamine H₂ receptor and gastric proton pump. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.13660
BibTeX
@article{Osmanovi2026,
author = {Osmanović, Amar and Salihović, Mirsada and Mehmedović, Amila and Turalić, Amila and Veljović, Elma and Pazalja, Mirha and Carradori, Simone and Špirtović-Halilović, Selma},
title = {Virtual screening of marine coumarins and xanthenes identifies novel acid-suppressive leads targeting histamine H₂ receptor and gastric proton pump},
journal = {Biomolecules and Biomedicine},
year = {2026},
doi = {10.17305/bb.2026.13660}
}
EUVIMED